Kenneth Harder
Vermogen: 7 M $ op 31-05-2026
Vermogen: 7 M $ op 31-05-2026
Kenneth Harder currently works at ME Therapeutics Holdings, Inc., as Director from 2023 and the University of British Columbia, as Associate Professor.
Dr. Harder received his doctorate degree in 1996 from the University of British Columbia and undergraduate degree in 1992 from Simon Fraser University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-07-2026 | 4.168.643 ( 13,87% ) | 7 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Directeur/Bestuurslid | 09-03-2023 |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ME Therapeutics Holdings, Inc.
ME Therapeutics Holdings, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau